Plavix Heart Attacks, Strokes, and Ulcers

October 11, 2013

Important Information

ClassAction.org is no longer reviewing claims for this case. The information here is for reference only. Up-to-date information and resources can be found here.

Comments |

At A Glance

This Alert Affects
Any patient given Plavix as a blood thinner to combat blood clots, heart attacks, and strokes.
Damages
Heart attack, stroke, gastrointestinal bleeding, or ulcers. Those with a history of peptic ulcer disease have been reported to suffer bleeding
Company(ies)
Bristol-Myers-Squibb / Sanofi-Aventis
Additional Details
Legal cases have now been launched. Generic versions of the drug, no longer in patent, remain in use.
Date
FDA concern reported in 1998. Plavix patent expired 2012.